MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s44313-025-00086-2

Медицинская библиотека · Blood research · 2025

SOX4 in chronic lymphocytic leukaemia: the forgotten transcription factor.

García-Muñoz Ricardo, Alberdi-Ballina Jone, Farfan-Quiroga Giovanna, Robles Eloy F, Larráyoz María José, Calasanz María José, Martínez-Climent José Ángel, Panizo Carlos, Larreina-Pérez Javier, Rincón-López Sofía, Atencio-Matos Johelys, Campeny-Najara Andrea, Esteban-Figuerola Ada, Hernandez-Perez Montserrat, Garrastachu-Zumaran Puy, Velasco-Ruiz María, de Gaona Estefanía Ruiz, Feliu Jesús

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: SRY-box transcription factor 4 (SOX4) is a transcription factor involved in early B cell development and has been implicated in various malignancies; however, its role in chronic lymphocytic leukemia (CLL) remains poorly understood. This study investigated the correlation between SOX4 expression and prognostic factors in CLL to determine its relevance to disease progression and clinical outcomes.

METHODS

A cohort of patients with CLL with a known immunoglobulin heavy chain variable region (IGHV) mutational status was analyzed for SOX4 expression using quantitative polymerase chain reaction (qPCR). Correlations between SOX4 levels and established prognostic markers including IGHV mutational status, cytogenetic abnormalities, and clinical outcomes were evaluated. Statistical analyses were performed to assess the association between SOX4 expression and patient survival.

RESULTS

Higher SOX4 expression was observed to be significantly associated with unmutated CLL (U-CLL) and adverse prognostic markers, including del(17)(p13). In contrast, lower SOX4 levels were observed in mutated CLL (M-CLL), and cytogenetic abnormalities were noted to be linked to favorable outcomes [del(13)(q21)]. Survival analysis indicated that elevated SOX4 expression was correlated with poor prognosis.

CONCLUSION

SOX4 expression stratifies CLL subtypes and aligns with established prognostic markers. High SOX4 levels are associated with aggressive disease phenotypes, whereas low SOX4 expression is associated with better clinical outcomes. These findings indicate that SOX4 may serve as a potential biomarker for disease classification and risk stratification. Further studies are required to elucidate the biological significance of this phenomenon.

Для цитирования: García-Muñoz Ricardo, Alberdi-Ballina Jone, Farfan-Quiroga Giovanna, Robles Eloy F, Larráyoz María José, Calasanz María José, Martínez-Climent José Ángel, Panizo Carlos, Larreina-Pérez Javier, Rincón-López Sofía, Atencio-Matos Johelys, Campeny-Najara Andrea, Esteban-Figuerola Ada, Hernandez-Perez Montserrat, Garrastachu-Zumaran Puy, Velasco-Ruiz María, de Gaona Estefanía Ruiz, Feliu Jesús. SOX4 in chronic lymphocytic leukaemia: the forgotten transcription factor.. Blood research. 2025. DOI: 10.1007/s44313-025-00086-2.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.